Table 1.
Common drugs used in metabolic disorders that can alter thyroid function tests and should be used with caution.
| Metabolic disorder | Drug | Effect |
|---|---|---|
| Glucometabolic dysfunction | Metformin | ↓ TSH levels in hypothyroid patients |
| Pioglitazone | ↓ TSH levels in hypothyroid patients | |
| Thiazolidinediones | Can induce thyroid-associated orbitopathy | |
| Cardiometabolic dysfunction | Amiodarone | Can cause both hypothyroidism and thyrotoxicosis |
| Beta blockers | ↓ circulating T3 levels | |
| Prazosin | ↑ TSH, ↑ T4, ↓ T3 | |
| Sodium nitroprusside | Prevents hypothyroidism in patients undergoing coronary artery bypass grafting | |
| Barometabolic disorders | Cholestyramine | ↓TH levels; can impair levothyroxine absorption |
| Colestipol | Transiently ↓T3 levels in some patients | |
| Statins | May have antiproliferative effect on thyroid cells; can alter thyroid size; effect of statin is lowered in TD | |
| Ezetimibe | Enhance conversion of T4 to T3 | |
| Viscerometabolic disorders | Interferon therapy used in liver and kidney diseases | Thyroid inflammation (both autoimmune and non-autoimmune), and either hyper- or hypothyroidism, which improve following discontinuation of interferon therapy |
| Alemtuzumab used as induction agent in renal transplantation | Autoimmune Graves' disease | |
| Lenalidomide used in renal cancer therapy | Hypothyroidism or hyperthyroidism | |
| Sunitinib used in renal cancer therapy | Transient hypothyroidism | |
| Clomiphene citrate used in PCOS | Associated with increased risk of thyroid cancer |
PCOS, polycystic ovary syndrome; T3, triiodothyronine; T4, thyroxine; TD, thyroid dysfunction; TH, thyroid hormone; TSH, thyroid stimulating hormone.